1. Home
  2. MRSN vs IPWR Comparison

MRSN vs IPWR Comparison

Compare MRSN & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • IPWR
  • Stock Information
  • Founded
  • MRSN 2001
  • IPWR 2007
  • Country
  • MRSN United States
  • IPWR United States
  • Employees
  • MRSN N/A
  • IPWR N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • IPWR Industrial Machinery/Components
  • Sector
  • MRSN Health Care
  • IPWR Industrials
  • Exchange
  • MRSN Nasdaq
  • IPWR Nasdaq
  • Market Cap
  • MRSN 47.1M
  • IPWR 52.8M
  • IPO Year
  • MRSN 2017
  • IPWR 2013
  • Fundamental
  • Price
  • MRSN $9.76
  • IPWR $5.64
  • Analyst Decision
  • MRSN Strong Buy
  • IPWR Hold
  • Analyst Count
  • MRSN 3
  • IPWR 1
  • Target Price
  • MRSN $33.00
  • IPWR N/A
  • AVG Volume (30 Days)
  • MRSN 69.2K
  • IPWR 61.2K
  • Earning Date
  • MRSN 11-12-2025
  • IPWR 11-13-2025
  • Dividend Yield
  • MRSN N/A
  • IPWR N/A
  • EPS Growth
  • MRSN N/A
  • IPWR N/A
  • EPS
  • MRSN N/A
  • IPWR N/A
  • Revenue
  • MRSN $34,769,000.00
  • IPWR $19,240.00
  • Revenue This Year
  • MRSN N/A
  • IPWR N/A
  • Revenue Next Year
  • MRSN N/A
  • IPWR $9,900.00
  • P/E Ratio
  • MRSN N/A
  • IPWR N/A
  • Revenue Growth
  • MRSN 16.14
  • IPWR N/A
  • 52 Week Low
  • MRSN $5.21
  • IPWR $3.77
  • 52 Week High
  • MRSN $70.75
  • IPWR $8.62
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 59.67
  • IPWR 55.74
  • Support Level
  • MRSN $8.76
  • IPWR $5.45
  • Resistance Level
  • MRSN $10.49
  • IPWR $5.95
  • Average True Range (ATR)
  • MRSN 0.84
  • IPWR 0.39
  • MACD
  • MRSN -0.06
  • IPWR 0.04
  • Stochastic Oscillator
  • MRSN 56.87
  • IPWR 69.46

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: